MLCK inhibitor peptide 18 10mg

Alternative_Names

NA
CAS

224579-74-2
Purity

>98%
MWt

1324.62
Formula

C60H105N23O11
Solubility

10 mM in H2O
Clinical_Information

No Development Reported
Pathway

Neuronal Signaling;Cytoskeleton
Target

CaMK;Myosin
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Identity

HGNC:7590
Gene

MYLK
Long gene name

myosin light chain kinase
Synonyms gene name
- myosin, light polypeptide kinase
Synonyms
- MLCK
- smMLCK
- MYLK1
- MLCK1
Synonyms name
- smooth muscle myosin light chain kinase
GenBank acession
- X85337
Locus

3q21.1
Discovery year

1995-07-14
Entrez gene record

4638
Pubmed identfication
- 8575746
RefSeq identity
- NM_053025
Classification
- Fibronectin type III domain containing
- Myosin light chain kinase family
- I-set domain containing
VEGA ID

OTTHUMG00000141304